MALAT1 and cancer: However, there are additional emerging lncRNAs that have been described as potential biomarkers in cancer, such as HOTAIR, DSCAM-AS1, and GATA3-AS1 in breast cancer [8,13,17], MALAT1 in lung cancer [67], H19 in colorectal cancer [68], HULC in liver cancer [69], UCA1 in bladder cancer [70], and DLEU1 in endometrial cancer [71].